unusual_whales on Nostr: Wegovy by Novo Nordisk, $NVO, is the first GLP-1 med to receive a positive opinion ...

Wegovy by Novo Nordisk, $NVO, is the first GLP-1 med to receive a positive opinion for reduced symptoms in people with obesity-related heart failure.

Unusual Whales has partnered with @Temaetfs to showcase the $HRTS ETF, the first GLP-1 ETF.

See more: https://t.co/9jXYVHxuRS

#news #finance #economics #stocks #options